{"id":"NCT02153398","sponsor":"AstraZeneca","briefTitle":"A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases","officialTitle":"An Open-label, Parallel-group, Multi-centre, Phase I/III Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Repeated Once-daily Oral Administration of D961H 10 mg and D961H 20 mg in Japanese Paediatric Patients 1 to 14 Years Old With Gastrointestinal Acid Related Diseases","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-06","primaryCompletion":"2016-04","completion":"2016-04","firstPosted":"2014-06-03","resultsPosted":"2017-01-19","lastUpdate":"2017-01-19"},"enrollment":55,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Gastric Ulcer (GU)","Duodenal Ulcer (DU)","Anastomotic Ulcer (AU)","Non-erosive Reflux Esophagitis Disease (NERD)","Reflux Esophagitis (RE)","Zollinger-Ellison Syndrome"],"interventions":[{"type":"DRUG","name":"D961H sachet 10 mg","otherNames":[]},{"type":"DRUG","name":"D961H capsule 10mg","otherNames":[]},{"type":"DRUG","name":"D961H capsule 20 mg","otherNames":[]}],"arms":[{"label":"Group 1: D961H sachet 10 mg","type":"EXPERIMENTAL"},{"label":"Group 2: D961H capsule 10mg","type":"EXPERIMENTAL"},{"label":"Group 3: D961H capsule 20 mg","type":"EXPERIMENTAL"},{"label":"Group 4: D961H capsule 10 mg","type":"EXPERIMENTAL"},{"label":"Group 5: D961H capsule 20 mg","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to assess the safety, pharmacokinetics, pharmacodynamics and efficacy of repeated once daily oral administration of D961H 10 mg and D961H 20 mg in Japanese paediatric patients aged 1 to 14 years old who either have a diagnosis of or are suspected to have gastric ulcer (GU), duodenal ulcer (DU), anastomotic ulcer (AU), non-erosive reflux esophagitis disease (NERD), reflux esophagitis (RE) or Zollinger-Ellison syndrome.","primaryOutcome":{"measure":"Disappearance of Heartburn at Week 8 by Patient Diaries","timeFrame":"8 weeks","effectByArm":[{"arm":"Group 1","deltaMin":2,"sd":null},{"arm":"Group 2","deltaMin":0,"sd":null},{"arm":"Group 3","deltaMin":0,"sd":null},{"arm":"Group 4","deltaMin":1,"sd":null},{"arm":"Group 5","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":15,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":10},"commonTop":["Nasopharyngitis","Headache","Diarrhoea","Upper respiratory tract infection","Nausea"]}}